Intrapartum group B Streptococcal prophylaxis and childhood weight gain.
Intrapartum group B Streptococcal prophylaxis and childhood weight gain.
复制标题
DOI:
10.1136/archdischild-2020-320638
复制
发表时间:
2021-11
期刊:
影响因子:
--
通讯作者:
Puopolo KM
中科院分区:
文献类型:
--
作者:
Mukhopadhyay S;Bryan M;Dhudasia MB;Quarshie W;Gerber JS;Grundmeier RW;Koebnick C;Sidell MA;Getahun D;Sharma AJ;Spiller MW;Schrag SJ;Puopolo KM
To determine the difference in rate of weight gain from birth to five years based on exposure to maternal group B Streptococcal (GBS) intrapartum antibiotic prophylaxis (IAP). Retrospective cohort study of 13,804 infants. Two perinatal centers and a primary pediatric care network in Philadelphia Term infants born 2007–2012, followed longitudinally from birth to 5 years of age. GBS IAP defined as penicillin, ampicillin, cefazolin, clindamycin or vancomycin administered ≥4 hours prior to delivery to the mother. Reference infants were defined as born to mothers without (vaginal delivery) or with other (cesarean delivery) intrapartum antibiotic exposure. Difference in rate of weight change from birth to 5 years was assessed using longitudinal rate regression. Analysis was a priori stratified by delivery mode and adjusted for relevant covariates. GBS IAP was administered to mothers of 2,444/13,804 (17.7%) children. GBS IAP-exposed children had a significantly elevated rate of weight gain in the first 5 years among vaginally-born (adjusted rate difference 1.44% [95% CI, 0.3%–2.6%]) and cesarean-born (3.52% [95% CI, 1.9%–5.2%]) children. At 5 years, the rate differences equated to an additional 0.24 kilograms among vaginally-born children and 0.60 kilograms among cesarean-born children. GBS-specific IAP was associated with a modest increase in rate of early childhood weight gain. GBS IAP is an effective intervention to prevent perinatal GBS disease-associated morbidity and mortality. However, these findings highlight the need to better understand effects of intrapartum antibiotic exposure on childhood growth and support efforts to develop alternate prevention strategies.
登录
查看更多内容
DOI:
10.1136/archdischild-2016-312546
发表时间:
2018-03-01
影响因子:
4.4
作者:
Berardi, Alberto;Pietrangiolillo, Zaira;Ferrari, Fabrizio
通讯作者:
Ferrari, Fabrizio
影响因子:
2.4
作者:
Fenton TR;Kim JH
通讯作者:
Kim JH
影响因子:
7.2
作者:
Fairlie, Tarayn;Zell, Elizabeth R.;Schrag, Stephanie
通讯作者:
Schrag, Stephanie
DOI:
10.1097/mpg.0000000000000928
发表时间:
2016-02-01
影响因子:
2.9
作者:
Corvaglia, Luigi;Tonti, Giacomo;Faldella, Giacomo
通讯作者:
Faldella, Giacomo
影响因子:
7.2
作者:
通讯作者:
--